TBPH icon

Theravance Biopharma

128 hedge funds and large institutions have $422M invested in Theravance Biopharma in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
128
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$11K
Puts
$3K
Net Calls
Net Calls Change

Top Buyers

1 +$2.43M
2 +$1.35M
3 +$897K
4
Millennium Management
Millennium Management
New York
+$754K
5
Citadel Advisors
Citadel Advisors
Florida
+$753K

Top Sellers

1 -$5.55M
2 -$1.3M
3 -$974K
4
Jane Street
Jane Street
New York
-$868K
5
AG
Algert Global
California
-$851K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$89.5M
2
$70.2M
3
$44.8M
4
$34.9M
5
$26M
6
$18.9M
7
$16.9M
8
$11.5M
9
$10.5M
10
$9.41M
11
$8.12M
12
$7.85M
13
$5.21M
14
$4.66M
15
$4.53M
16
$4.13M
17
$3.69M
18
$3.67M
19
$2.96M
20
$2.88M
21
$2.77M
22
$2.47M
23
$2.12M
24
$2.07M
25
$1.97M